Pregabalin 150mg capsules (brand names like Lyrica, APO‑Pregabalin, Pregabalin‑WGR) are Schedule 4 prescription‑only medicines available in 56‑capsule packs under the PBS subsidy. The initial dose is typically 150 mg daily (once or split into two doses), increased gradually to 300–600 mg/day depending on condition.

It’s prescribed for neuropathic pain, adjunctive therapy in partial seizures, and other conditions (e.g., fibromyalgia). Capsules are swallowed whole, with or without food. Common side effects include dizziness, drowsiness, dry mouth, weight gain, and peripheral oedema; patients should avoid driving until they know how it affects them.

Renal dose adjustments are needed for impaired kidney function. Always follow your prescriber’s instructions and report side effects via the TGA.